Saturday 21 October, 2017
Edition: English (US)
MMJ Observer
Tag Archives: Insys Therapeutics Inc (NASDAQ:INSY)
insys-therapeutics-inc

Insys Therapeutics Inc (NASDAQ:INSY) reported that like so many shareholders in the government and in the healthcare community, they intend to address the grave national challenge linked to the abuse and misuse of opioids that has led to unnecessary...

By Brandon Manns on Sep 1st, 2017

The charges against several executives of Insys Therapeutics Inc (NASDAQ:INSY) discussed in the DOJ PR relate to initially disclosed probe. The company is cooperating with all relevant authorities in ongoing investigations and is dedicated to...

By Sophia T on Dec 28th, 2016
insys-therapeutics-inc

Insys Therapeutics Inc (NASDAQ:INSY) has recently released its third quarter earnings report. Q3 Financial Results The company had a net revenue of $55.20 million, down by 39.50% year-over-year from $91.30 million. Insys Therapeutics had sales...

By Jaime Williams on Dec 2nd, 2016

Insys Therapeutics Inc (NASDAQ:INSY), better known for its pharmaceutical offerings, is in deep trouble after its top management executives have been found involved in off-label and illegal marketing of Subsys. It’s one of the core products...

By Steven Russell on Feb 18th, 2016

Insys Therapeutics Inc (NASDAQ:INSY), better known for its offerings in the pharmaceutical field, is facing security class lawsuit in the country after its top management executives were found involved in illegal marketing activities. As per...

By Emily Gibson on Feb 17th, 2016

In a recent public statement, Wolf Haldenstein Adler Freeman & Herz LLP announced that Insys Therapeutics Inc (NASDAQ:INSY) was facing class action for indulging into illegal and off-label marketing activities to promote its core product....

By Steven Russell on Feb 16th, 2016